Jury Still Out on Cardiovascular Safety of Testosterone

Despite a new meta-analysis claiming to show that testosterone replacement therapy for men with hypogonadism does not increase the risk of cardiovascular outcomes such as heart attack or stroke, experts say the jury has still not been tried. A more definitive answer for the cardiovascular safety of testosterone therapy will come from the AbbVie-sponsored TRAVERSE […]

Continue Reading

Erectile Dysfunction Drugs Linked With Risk for Eye Problems

According to new research, regular use of certain erectile dysfunction drugs – phosphodiesterase type 5 inhibitors (PDE5 inhibitors) – may be associated with an increased risk of several adverse eye effects. In a cohort study of 213,033 men, the risk of developing severe retinal detachment, retinal vascular occlusion or ischemic optic neuropathy increased by 85% […]

Continue Reading